A Multiple-Ascending Dose Study in Type 2 Diabetes Mellitus Patients
PHASE1
The study drug LY2393910 is being evaluated as a possible treatment for dia...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Multi-dose, Dose Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of DDO-3055 Tablets in Patients With Anemia of Non-dialysis Chronic Kidney Diseases.
PHASE1
The study is being conducted to evaluate the safety, tolerability, pharmaco...
Status
Unknown
Location
Beijing Friendship Hospital,Capital Medical University